CIBC Private Wealth Group
CGON icon

CIBC Private Wealth Group’s CG Oncology CGON Stock Holding History

CIBC Private Wealth Group’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$20.8K Buy
+500
New +$20.7K ﹤0.01% 2151

Other funds holding CGON

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $643M AUM 343.43% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

CIBC Private Wealth Group's CGON Position: Q4 2025 in Review

CIBC Private Wealth Group opened a new position in CG Oncology (CGON) in Q4 2025: 500 shares worth $20.8K. The stake represents ﹤0.01% of the portfolio and ranks #2151 among its holdings.

195 funds tracked by Wall St. Rank hold CGON as of Q4 2025.

  • CIBC Private Wealth Group held 500 shares of CG Oncology worth $20.8K as of Q4 2025.
  • CG Oncology was a new CIBC Private Wealth Group position in Q4 2025.
  • CG Oncology made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #2151 holding.
  • 195 funds tracked by Wall St. Rank held CG Oncology as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.